Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lindsey Buhring"'
Autor:
David R Powell, Deon D Doree, Christopher M DaCosta, Kenneth A Platt, Robert Brommage, Lindsey Buhring, Jean-Pierre Revelli, Melanie K Shadoan
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.
David R Powell,1 Deon D Doree,1 Christopher M DaCosta,1 Kenneth A Platt,2 Robert Brommage,1 Lindsey Buhring,1 Jean-Pierre Revelli,1 Melanie K Shadoan1 1Department of Pharmaceutical Biology, Lexicon Pharmaceuticals, Inc, The Woodlands, TX, USA; 2Depar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f33643fb27a8877ae6bb4e8757ee67c5
https://www.dovepress.com/mice-lacking-gpr75-are-hypophagic-and-thin-peer-reviewed-fulltext-article-DMSO
https://www.dovepress.com/mice-lacking-gpr75-are-hypophagic-and-thin-peer-reviewed-fulltext-article-DMSO
Autor:
David R, Powell, Deon D, Doree, Christopher M, DaCosta, Kenneth A, Platt, Robert, Brommage, Lindsey, Buhring, Jean-Pierre, Revelli, Melanie K, Shadoan
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Purpose Humans with haploinsufficiency of GPR75, an orphan GPCR, are thin. Gpr75 knockout (KO) mice are also thin with improved glucose homeostasis. We wanted to confirm these findings in Gpr75 KO mice and determine whether decreased energy intake an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::297a542c63b91289d72014b3b34f4748
https://pubmed.ncbi.nlm.nih.gov/35023939
https://pubmed.ncbi.nlm.nih.gov/35023939
Autor:
Christopher M. DaCosta, J. Wingert, Peter Vogel, Lindsey Buhring, R. Read, Melanie K. Shadoan, Gwenn M. Hansen
Publikováno v:
Veterinary Pathology. 48:642-654
Congenital generalized lipodystrophy (CGL) comprises a heterogeneous group of rare diseases associated with partial or total loss of adipose tissue. Of these, autosomal recessive Berardinelli–Seip congenital lipodystrophy (BSCL) is characterized by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0ce603b46a4bdbfe2973f5b8f0a558e
https://doi.org/10.1177/0300985810383870
https://doi.org/10.1177/0300985810383870
Autor:
David R. Powell, Christopher M. DaCosta, Jason Gay, Zhi-Ming Ding, Melinda Smith, Jennifer Greer, Deon Doree, Sabrina Jeter-Jones, Faika Mseeh, Lawrence A. Rodriguez, Angela Harris, Lindsey Buhring, Kenneth A. Platt, Peter Vogel, Robert Brommage, Melanie K. Shadoan, Arthur T. Sands, Brian Zambrowicz
Publikováno v:
American journal of physiology. Endocrinology and metabolism. 304(2)
Sodium-glucose cotransporter 2 (SGLT2) is the major, and SGLT1 the minor, transporter responsible for renal glucose reabsorption. Increasing urinary glucose excretion (UGE) by selectively inhibiting SGLT2 improves glycemic control in diabetic patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9c2205731253f0e0d28fbca1eb23ca
https://pubmed.ncbi.nlm.nih.gov/23149623
https://pubmed.ncbi.nlm.nih.gov/23149623
Autor:
David B. Rawlins, Qingyun Liu, Amr Nouraldeen, Yiling Xie, Nicole Cathleen Goodwin, Jennifer Bardenhagen, Zheng Y. Almstead, Faika Mseeh, Christopher M. DaCosta, S. David Kimball, Jason P. Healy, Melanie K. Shadoan, Ross Mabon, David R. Powell, Alan G. E. Wilson, Lindsey Buhring, Bryce Alden Harrison
Publikováno v:
Journal of medicinal chemistry. 52(20)
The prevalence of diabetes throughout the world continues to increase and has become a major health issue. Recently there have been several reports of inhibitors directed toward the sodium-dependent glucose cotransporter 2 (SGLT2) as a method of main
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b090868779dde7f75c5ce12511e6662
https://pubmed.ncbi.nlm.nih.gov/19785435
https://pubmed.ncbi.nlm.nih.gov/19785435